Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1984 Jun;39(6):448–452. doi: 10.1136/thx.39.6.448

Alveolar macrophage dysfunction in malignant lung tumours.

E Lemarie, P Carre, M F Legrand, M Lavandier, E Boissinot, M Renoux, G Renoux
PMCID: PMC459828  PMID: 6463914

Abstract

Alveolar macrophage chemotaxis was measured in 129 individuals--13 normal volunteers, 15 tumour free patients with recent bronchopulmonary infections, 10 patients with chronic bronchitis, 29 patients with endothoracic sarcoidosis, 48 patients with primary bronchial carcinoma and 14 patients with pulmonary metastases from various origins. Chemotaxis was tested in the presence of either zymosan activated autologous serum, N-formyl-methionine-leucyl-phenylalanine (F-Met-Leu-Phe), or zymosan activated human AB serum. Alveolar macrophage chemotaxis was significantly less in patients with bronchial carcinoma than in healthy volunteers (p less than 0.01). Chemotaxis was significantly more depressed in samples obtained from the neighbourhood of the tumour than in samples from the opposite lung. Defective chemotaxis was also found in patients with sarcoidosis. In contrast, the presence of lung metastases did not affect chemotaxis. A recent bronchopulmonary infection was associated with significantly increased (p less than 0.02) chemotaxis in tumour free patients but not in patients with a primary lung tumour. The findings suggest that an intrinsic functional defect of alveolar macrophages might favour the development of bronchogenic carcinoma.

Full text

PDF
448

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aksamit R. R., Falk W., Leonard E. J. Chemotaxis by mouse macrophage cell lines. J Immunol. 1981 Jun;126(6):2194–2199. [PubMed] [Google Scholar]
  2. Boetcher D. A., Leonard E. J. Abnormal monocyte chemotactic response in cancer patients. J Natl Cancer Inst. 1974 Apr;52(4):1091–1099. doi: 10.1093/jnci/52.4.1091. [DOI] [PubMed] [Google Scholar]
  3. Cianciolo G. J., Snyderman R. Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants. J Clin Invest. 1981 Jan;67(1):60–68. doi: 10.1172/JCI110033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Falk W., Leonard E. J. Human monocyte chemotaxis: migrating cells are a subpopulation with multiple chemotaxin specificities on each cell. Infect Immun. 1980 Sep;29(3):953–959. doi: 10.1128/iai.29.3.953-959.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hibbs J. B., Jr, Chapman H. A., Jr, Weinberg J. B. The macrophage as an antineoplastic surveillance cell: biological perspectives. J Reticuloendothel Soc. 1978 Nov;24(5):549–570. [PubMed] [Google Scholar]
  6. Hocking W. G., Golde D. W. The pulmonary-alveolar macrophage (first of two parts). N Engl J Med. 1979 Sep 13;301(11):580–587. doi: 10.1056/NEJM197909133011104. [DOI] [PubMed] [Google Scholar]
  7. Kaltreider H. B. Alveolar macrophages. Enhancers or suppressors of pulmonary immune reactivity? Chest. 1982 Sep;82(3):261–262. doi: 10.1378/chest.82.3.261. [DOI] [PubMed] [Google Scholar]
  8. McCombs C. C., Michalski J. P., Westerfield B. T., Light R. W. Human alveolar macrophages suppress the proliferative response of peripheral blood lymphocytes. Chest. 1982 Sep;82(3):266–271. doi: 10.1378/chest.82.3.266. [DOI] [PubMed] [Google Scholar]
  9. Nathan C. F., Murray H. W., Cohn Z. A. The macrophage as an effector cell. N Engl J Med. 1980 Sep 11;303(11):622–626. doi: 10.1056/NEJM198009113031106. [DOI] [PubMed] [Google Scholar]
  10. Normann S. J., Sorkin E. Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro. Cancer Res. 1977 Mar;37(3):705–711. [PubMed] [Google Scholar]
  11. Pasternack G. R., Snyderman R., Pike M. C., Johnson R. J., Shin H. S. Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor. J Exp Med. 1978 Jul 1;148(1):93–102. doi: 10.1084/jem.148.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pike M. C., Snyderman R. Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. J Immunol. 1976 Oct;117(4):1243–1249. [PubMed] [Google Scholar]
  13. Privalova L. I., Katsnelson B. A., Osipenko A. B., Yushkov B. N., Babushkina L. G. Response of a phagocyte cell system to products of macrophage breakdown as a probable mechanism of alveolar phagocytosis adaptation to deposition of particles of different cytotoxicity. Environ Health Perspect. 1980 Apr;35:205–218. doi: 10.1289/ehp.8035205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Reynolds H. Y., Fulmer J. D., Kazmierowski J. A., Roberts W. C., Frank M. M., Crystal R. G. Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest. 1977 Jan;59(1):165–175. doi: 10.1172/JCI108615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Shellito J., Caldwell J. L., Kaltreider H. B. Immune functions of murine alveolar macrophages: binding of lymphocytes and support of lymphocyte proliferation. Exp Lung Res. 1983 Feb;4(2):93–107. doi: 10.3109/01902148309055007. [DOI] [PubMed] [Google Scholar]
  16. Snyderman R., Pike M. C., Altman L. C. Abnormalities of leukocyte chemotaxis in human disease. Ann N Y Acad Sci. 1975 Jun 13;256:386–401. doi: 10.1111/j.1749-6632.1975.tb36065.x. [DOI] [PubMed] [Google Scholar]
  17. Snyderman R., Pike M. C., Blaylock B. L., Weinstein P. Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. J Immunol. 1976 Mar;116(3):585–589. [PubMed] [Google Scholar]
  18. Snyderman R., Pike M. C. Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance. Am J Pathol. 1977 Sep;88(3):727–739. [PMC free article] [PubMed] [Google Scholar]
  19. Sone S., Fidler I. J. Activation of rat alveolar macrophages to the tumoricidal state in the presence of progressively growing pulmonary metastases. Cancer Res. 1981 Jun;41(6):2401–2406. [PubMed] [Google Scholar]
  20. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES